Veradermics, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
MANE
Veradermics, INCJohn W Childs, a Director of Veradermics, Inc, sold 100,000 shares of common stock on August 12, 2026.
NYSE
MANE
Veradermics, INCVeradermics, Inc. secures a $30 million investment from Suvretta Capital through a private placement of pre-funded warrants.
NYSE
MANE
Veradermics, INCVeradermics Director John W. Childs filed an amended Form 4 to correct the nature of indirect beneficial ownership for 294,117 common shares.
NYSE
MANE
Veradermics, INCSuvretta Capital Management and affiliated funds significantly increased their beneficial ownership in Veradermics, Inc. through open market purchases in early February 2026.